Announcement on Convening the 2025 Annual Performance Briefing
Filed with SSE · · 2 pages · Chinese
Vcanbio Cell & Gene Engineering Corp., Ltd. on 6ix
Earlier from Vcanbio Cell & Gene Engineering
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Return of Raised Funds Temporarily Used to Supplement Current Capital
- Indicative Announcement on Convening the 2025 Annual General Meeting
- Announcement on 2025 Annual Profit Distribution Plan
- Announcement on Progress in Wholly-owned Subsidiary’s Clinical Trial for VUM02 Injection
Later from Vcanbio Cell & Gene Engineering
- Announcement on Progress in Redemption of Temporarily Idle Raised Funds Used for Cash Management upon Expiration and Continuously Conducting Cash Management
- Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual Report
- Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Tianjin Jurisdiction and Semi-annual Performance Briefing
- Announcement on Measures in the Form of Warning Letters Received by the Company and Relevant Persons
- (600645)"Vcanbio Cell & Gene Engineering Corp., Ltd."Announcement on Redemption upon Maturity of Cash Management Products Purchased with Idle Raised Funds
Follow Vcanbio Cell & Gene Engineering into a list and get an email when it puts out news.
Follow Vcanbio Cell & Gene Engineering